Impact of Oat (Avena sativa L.) on Metabolic Syndrome and Potential Physiological Mechanisms of Action: A Current Review

J Agric Food Chem. 2023 Oct 18;71(41):14838-14852. doi: 10.1021/acs.jafc.3c02304. Epub 2023 Oct 5.

Abstract

Oat (Avena sativa L.), an annual herbaceous plant belonging to the Gramineae family, is widely grown in various regions including EU, Canada, America, Australia, etc. Due to the nutritional and pharmacological values, oats have been developed into various functional food including fermented beverage, noodle, cookie, etc. Meanwhile, numerous studies have demonstrated that oats may effectively improve metabolic syndrome, such as dyslipidemia, hyperglycemia, atherosclerosis, hypertension, and obesity. However, the systematic pharmacological mechanisms of oats on metabolic syndrome have not been fully revealed. Therefore, in order to fully explore the benefits of oat in food industry and clinic, this review aims to provide up-to-date information on oat and its constituents, focusing on the effects on metabolic syndrome.

Keywords: Avena sativa L.; Oat; metabolic mechanisms; metabolic syndrome; multiple targets.

Publication types

  • Review

MeSH terms

  • Australia
  • Avena* / metabolism
  • Canada
  • Edible Grain
  • Metabolic Syndrome* / drug therapy